Abu Dhabi, UAE – The fourth Dubai Stem Cell Conference kicked off today in Dubai, with the participation of more than 500 physicians and specialists,
including 26 leading scientists, medical professionals, and industry experts
in the field of stem cells, representing several countries around the world.
The conference is being held at the Mövenpick Grand Al Bustan Hotel and will continue for two days.
It is organized by the First Stem Cell and Genomics Laboratory (FSG), with the support of the Dubai Health Authority.
The conference aims to highlight the latest scientific and research developments in the field of stem cells and regenerative medicine.
Exploring innovative treatment methods
It also aims to explore the potential for their application in developing innovative treatment methods for intractable diseases.
In her opening remarks, Dr. Fatima Al Hashimi, Conference Chair and Executive Director of the First Stem Cell and Genomics Laboratory, emphasized
that this year’s conference features a distinguished group of speakers and experts
from the United States, Japan, Sweden, Finland, Germany, the Netherlands, Qatar, and the UAE.
This provides a high-level scientific platform for exchanging experiences, ideas, and innovations in this vital sector.
She explained that the conference sessions focus on the latest research related to stem cell therapy,
advanced treatments in regenerative medicine, and their impact on
developing medical technologies and improving the quality of healthcare.
Treatment of chronic and complex diseases
She also noted that this type of treatment is poised to become an effective option
for treating a large number of chronic and complex diseases in the coming years.
The conference program includes six specialized workshops discussing the latest scientific developments.
In addition, there is an awareness session on modern technologies and successful clinical trials.
The conference also witnessed the signing of two strategic memoranda of understanding,
the first with the Center for Molecular Biology and Genomics (MBG), and the second with TCURX.
These agreements aim to support research collaboration and the development of therapeutic innovation.
Participants will receive 14 Continuing Medical Education (CME) credits recognized by the Dubai Health Authority.
This reflects the conference’s commitment to supporting sustainable professional development
and enhancing Dubai’s position as a global hub for advanced biomedicine.
